Dow Futures inch up, as investors maintain a cautious optimism for a sustainable resolution in the Middle East conflict. Shares of SpaceX and Advanced Micro Devices experienced a decline in premarket trading, as traders analysed remarks made by Elon Musk that influenced both equities. Elsewhere, shares of Novo Nordisk listed in Copenhagen decline following sales of its key Wegovy weight-loss drug falling short of estimates.

Dow futures experienced a modest increase on Wednesday, supported by optimism regarding a potential resolution to the ongoing tensions in the Middle East. In contrast, shares of SpaceX declined as investors expressed concerns over the company’s high levels of expenditure. By 03:09, the Dow futures contract had increased by 156 points, or 0.3%, S&P 500 futures had risen by 29 points, or 0.4%, and Nasdaq 100 futures had advanced by 91 points, or 0.3%. The primary indices on Wall Street experienced an upward movement in the previous session. Sentiment was buoyed in part by U.S. Treasury Secretary Scott Bessent, who indicated that an agreement with Iran to reopen the Strait of Hormuz could soon be finalised, while regional negotiator Qatar provided optimistic remarks regarding the progress of negotiations. Oil prices declined following the news, alleviating some concerns regarding a possible surge in energy-driven inflation and subsequent increases in central bank interest rates. Government bonds experienced gains, as U.S. Treasury yields declined. However, the rally moderated somewhat overnight following remarks from Kansas City Federal Reserve President Jeffrey Schmid, who contended that achieving the central bank’s 2% inflation target will necessitate “tighter policy.” Simultaneously, shares of Palantir surged by nearly 30% following the data analytics firm’s upward revision of its full-year revenue guidance and the presentation of quarterly sales growth that CEO Alex Karp characterised as “otherworldly.” Snap’s shares experienced an uptick following a reduction in losses from the short-form video app maker, while industrial bellwether Caterpillar saw an increase of over 5% due to an enhanced sales forecast for 2026. Semiconductor companies experienced another robust session, as traders seemed to be “increasingly willing to lean back into the capex theme that looked under pressure” during a period of volatility in July, according to analysts. Demand for AI systems and the infrastructure that supports them has remained robust, despite growing concerns regarding the sustainability of substantial investments in this emerging technology.

U.S. President Donald Trump indicated that the White House engaged in “very good” discussions with Iran during an extensive round of negotiations on Tuesday, heightening expectations that the protracted conflict in the Gulf may be nearing a resolution. In particular, Trump informed that the Strait of Hormuz, a crucial conduit for international shipping, will be “open very soon,” further asserting that Iran is poised to “get hit really hard” if Tehran reneges on a potential agreement. Nonetheless, analysts have pointed out that investors have grown accustomed to a repetitive cycle of threats and pullbacks in the Middle East conflict. Last weekend, Trump cancelled new military strikes on Iran, following a series of limited air attacks from both parties that effectively undermined the ceasefire agreement established in June. “Markets have seen plenty of false dawns throughout this conflict, so plenty of attention will be on whether a deal is announced imminently and its details,” the analysts said in a note. Brent crude futures, the global oil benchmark, were last observed trading up by 0.8% at $80.01 a barrel, following a decline to just above $79 a barrel in the previous session.

On the earnings front, shares of SpaceX experienced a decline of over 7% in after-hours trading on Wednesday as investors analysed the company’s inaugural earnings report following its significant public debut in June, along with remarks from CEO Elon Musk. Analysts concentrated on SpaceX’s free cash flow for the initial two quarters of the year, which experienced a significant decline into negative territory. In the second quarter, the company incurred capital expenditures amounting to $18.36 billion, reflecting an increase of $2.8 billion compared to the previous year. Of that spending, 15.8 billion dollars originated from SpaceX’s AI unit. SpaceX, with its diverse operations ranging from rocket launches to satellite internet, emphasised its ambitions to establish itself as a significant player in the AI sector during its pitch to investors ahead of the IPO. Yet it was the division providing thousands of satellites in low-Earth orbit that continued to be SpaceX’s primary source of revenue. Revenue at the segment surged by 66% to $4.3 billion, driven by a doubling of subscribers to SpaceX’s Starlink service. Overall, second-quarter sales surged by 92% to $7.8 billion, while SpaceX’s net loss contracted. In his characteristically ambitious manner, Musk set a goal for eventual revenue of $1 trillion and suggested that the company might initiate the launch of data centers into orbit next year. “[T]he revenue and EBITDA results are great, but the cash flow numbers are pretty ugly,” analysts said in a note.

Advanced Micro Devices experienced a decline in after-hours trading, influenced by a separate announcement from Musk indicating that SpaceX would cease its procurement of processors from the chip manufacturer. Musk praised AMD’s competitor, Nvidia, stating that SpaceX has opted to “build exclusively” on Nvidia’s Blackwell AI server due to it being the “best architecture. Previously, Musk had indicated that SpaceX and Tesla, his electric vehicle manufacturing firm, would utilise chips from both AMD and Nvidia. The comments overshadowed what were impressive quarterly sales from AMD. The semiconductor firm reported revenue of $11.5 billion for the quarter ending June 27, slightly exceeding Wall Street expectations. AMD has achieved record chip sales for the fifth consecutive quarter. Further emphasising the company’s status as a primary beneficiary of the AI surge, AMD’s data center revenue soared to a record high of $6.7 billion, indicating that this division now constitutes 58% of total sales, up from 42% a year prior.

Novo Nordisk has raised its full-year guidance, indicating that annual sales and operating profit are projected to decline less than previously anticipated, driven by sustained demand for its weight-loss medications. Shares experienced a decline in U.S. trading on Tuesday following the company’s Wegovy pill falling short of sales expectations, coupled with underwhelming results from an experimental next-generation weight-loss drug study. Novo’s shares listed in Copenhagen experienced a decline following the market’s opening on Wednesday. The Danish drugmaker now anticipates adjusted sales and operating profit to decrease by as much as 6% at constant exchange rates this year, representing an enhancement from its previous forecast of a decline ranging from 4% to 12% for both metrics. Sales of the oral version of Wegovy reached 3.2 billion Danish kroner in the second quarter, approximately $500 million, which was below the 3.3 billion kroner anticipated by analysts surveyed by FactSet. The injectable form of Wegovy generated 19.48 billion kroner in sales during the quarter.